RESTYLANE SHAYPE
LIVE

Serial Number

98237535

Owner

Galderma Holding SA

Attorney

Katherine P. Califa

Filing Date

Oct 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RESTYLANE SHAYPE Trademark

Serial Number: 98237535

RESTYLANE SHAYPE is a trademark filed by Galderma Holding SA on October 24, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Galderma Holding SA (96 trademarks)

Zählerweg 10

Entity Type: 33

Trademark Details

Filing Date

October 24, 2023

Registration Date

Not Registered

Published for Opposition

January 7, 2025

Goods & Services

Medical devices, namely, synthetic implants in gel form; medical devices, namely, synthetic implants in gel form for treating lines, wrinkles, scars, lips, for tightening the face and body and for rejuvenating the skin; skin care kits comprising medical devices, namely, synthetic implants in gel form for treating lines, wrinkles, scars, lips, for tightening the face and body and for rejuvenating the skin; injection syringes, and injection devices for pharmaceutical products, sold together as a unit; injection syringes; injection devices for pharmaceutical products

Pharmaceutical preparations and substances, namely, creams and gels for use in dermatology; injectable pharmaceutical products for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; injectable dermal fillers; pharmaceutical preparations and substances, namely, creams and gels for use in skin care; muscle relaxants; medicinal preparations for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; medical preparations consisting of a dermatological preparation; pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; skin-care kits comprising dermatological preparations, and pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin, sold together as a unit; pharmaceutical preparations for use in non-surgical restorative and beauty care treatments and in aesthetic dermatology; synthetic injectable material for use in the treatment of fine lines and wrinkles and for rejuvenating the skin

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 26, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 26, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 19, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 18, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 18, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 18, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 15, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 15, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 15, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 15, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 15, 2024 COAR
ASSIGNED TO EXAMINER
Nov 15, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2024 CRFA
ASSIGNED TO LIE
Sep 4, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2023 NWOS
NEW APPLICATION ENTERED
Oct 27, 2023 NWAP